Matthew E. Korenberg - Feb 15, 2023 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Role
President & COO
Signature
/s/ Andrew Reardon, Attorney-in-Fact for Matthew E. Korenberg
Stock symbol
LGND
Transactions as of
Feb 15, 2023
Transactions value $
-$210,912
Form type
4
Date filed
2/17/2023, 06:23 PM
Previous filing
Dec 30, 2022
Next filing
Feb 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Tax liability -$211K -2.89K -3.12% $72.98 89.7K Feb 15, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.